Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 353074, 12 pages
http://dx.doi.org/10.1155/2015/353074
Research Article

Dose Response of Endotoxin on Hepatocyte and Muscle Mitochondrial Respiration In Vitro

1Department of Intensive Care Medicine, Inselspital, Bern University Hospital and University of Bern, Freiburgstraße 10, 3010 Bern, Switzerland
2Graduate School for Cellular and Biomedical Sciences, University of Bern, Switzerland
3Department of Anesthesiology and Pain Therapy, Inselspital, Bern University Hospital and University of Bern, 3010 Bern, Switzerland

Received 5 June 2014; Revised 22 August 2014; Accepted 8 September 2014

Academic Editor: Marko Ljubkovic

Copyright © 2015 Victor Jeger et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Beutler, “Tlr4: central component of the sole mammalian LPS sensor,” Current Opinion in Immunology, vol. 12, no. 1, pp. 20–26, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. M. P. Fink and M. P. Fink, “Cytopathic hypoxia: Mitochondrial dysfunction as mechanism contributing to organ dysfunction in sepsis,” Critical Care Clinics, vol. 17, no. 1, pp. 219–237, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. M. P. Fink, “Bench-to-bedside review: cytopathic hypoxia,” Critical Care, vol. 6, no. 6, pp. 491–499, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Singer and D. Brealey, “Mitochondrial dysfunction in sepsis,” Biochemical Society Symposium, vol. 66, pp. 149–166, 1999. View at Google Scholar · View at Scopus
  5. D. Brealey, M. Brand, I. Hargreaves et al., “Association between mitochondrial dysfunction and severity and outcome of septic shock,” The Lancet, vol. 360, no. 9328, pp. 219–223, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. J.-L. Vincent, Y. Sakr, C. L. Sprung et al., “Sepsis in European intensive care units: results of the SOAP study,” Critical Care Medicine, vol. 34, no. 2, pp. 344–353, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. D. C. Angus, W. T. Linde-Zwirble, J. Lidicker, G. Clermont, J. Carcillo, and M. R. Pinsky, “Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care,” Critical Care Medicine, vol. 29, no. 7, pp. 1303–1310, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. J. A. Russell, J. Singer, G. R. Bernard et al., “Changing pattern of organ dysfunction in early human sepsis is related to mortality,” Critical Care Medicine, vol. 28, no. 10, pp. 3405–3411, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. M. P. Callery, T. Kamei, and W. Flye, “Kupffer cell blockade increases mortality during intra-abdominal sepsis despite improving systemic immunity,” Archives of Surgery, vol. 125, no. 1, pp. 36–40, 1990. View at Publisher · View at Google Scholar · View at Scopus
  10. S. W. Chensue, P. D. Terebuh, D. G. Remick, W. E. Scales, and S. L. Kunkel, “In vivo biologic and immunohistochemical analysis of interleukin-1 α, β and tumor necrosis factor during experimental endotoxemia: kinetics, kupffer cell expression, and glucocorticoid effects,” The American Journal of Pathology, vol. 138, no. 2, pp. 395–402, 1991. View at Google Scholar · View at Scopus
  11. K. Takeda, T. Kaisho, and S. Akira, “Toll-like receptors,” Annual Review of Immunology, vol. 21, pp. 335–376, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. R. L. Kitchens, P.-Y. Wang, and R. S. Munford, “Bacterial lipopolysaccharide can enter monocytes via two CD14-dependent pathways,” The Journal of Immunology, vol. 161, no. 10, pp. 5534–5545, 1998. View at Google Scholar · View at Scopus
  13. N. Thieblemont and S. D. Wright, “Transport of bacterial lipopolysaccharide to the Golgi apparatus,” The Journal of Experimental Medicine, vol. 190, no. 4, pp. 523–534, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. W. L. Beatty, S. Méresse, P. Gounon et al., “Trafficking of Shigella lipopolysaccharide in polarized intestinal epithelial cells,” Journal of Cell Biology, vol. 145, no. 4, pp. 689–698, 1999. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Forestier, E. Moreno, J. Pizarro-Cerda, and J.-P. Gorvel, “Lysosomal accumulation and recycling of lipopolysaccharide to the cell surface of murine macrophages, an in vitro and in vivo study,” The Journal of Immunology, vol. 162, no. 11, pp. 6784–6791, 1999. View at Google Scholar · View at Scopus
  16. T. Vasselon, E. Mailman, R. Thieringer, and P. A. Detmers, “Internalization of monomeric lipopolysaccharide occurs after transfer out of cell surface CD14,” Journal of Experimental Medicine, vol. 190, no. 4, pp. 509–521, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. V. A. K. Rathinam and K. A. Fitzgerald, “Lipopolysaccharide sensing on the inside,” Nature, vol. 501, no. 7466, pp. 173–175, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. N. Kayagaki, M. T. Wong, I. B. Stowe et al., “Noncanonical inflammasome activation by intracellular LPS independent of TLR4,” Science, vol. 341, no. 6151, pp. 1246–1249, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. I. Diaz-Laviada, J. Ainaga, M. Teresa Portoles, J. L. Carrascosa, A. M. Muncio, and R. Pagani, “Binding studies and localization of Escherichia coli lipopolysaccharide in cultured hepatocytes by an immunocolloidal-gold technique,” The Histochemical Journal, vol. 23, no. 5, pp. 223–228, 1991. View at Publisher · View at Google Scholar · View at Scopus
  20. I. Marzo, S. A. Susin, P. X. Petit et al., “Caspases disrupt mitochondrial membrane barrier function,” FEBS Letters, vol. 427, no. 2, pp. 198–202, 1998. View at Publisher · View at Google Scholar · View at Scopus
  21. R. J. Clem, E. H.-Y. Cheng, C. L. Karp et al., “Modulation of cell death by Bcl-x(L) through caspase interaction,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 2, pp. 554–559, 1998. View at Publisher · View at Google Scholar · View at Scopus
  22. Q. Sun, W. Gao, P. Loughran et al., “Caspase 1 activation is protective against hepatocyte cell death by up-regulating beclin 1 protein and mitochondrial autophagy in the setting of redox stress,” The Journal of Biological Chemistry, vol. 288, no. 22, pp. 15947–15958, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. V. Jeger, S. Djafarzadeh, S. M. Jakob, and J. Takala, “Mitochondrial function in sepsis,” European Journal of Clinical Investigation, vol. 43, no. 5, pp. 532–542, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. M. M. Levy, A. Artigas, G. S. Phillips et al., “Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study,” The Lancet Infectious Diseases, vol. 12, no. 12, pp. 919–924, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Fredriksson, U. Flaring, C. Guillet, J. Wernerman, and O. Rooyackers, “Muscle mitochondrial activity increases rapidly after an endotoxin challenge in human volunteers,” Acta Anaesthesiologica Scandinavica, vol. 53, no. 3, pp. 299–304, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. K. Fredriksson, F. Hammarqvist, K. Strigård et al., “Derangements in mitochondrial metabolism in intercostal and leg muscle of critically ill patients with sepsis-induced multiple organ failure,” The American Journal of Physiology: Endocrinology and Metabolism, vol. 291, no. 5, pp. E1044–E1050, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. S. Portmann, R. Fahrner, A. Lechleiter et al., “Antitumor effect of SIRT1 inhibition in human HCC tumor models in vitro and in vivo,” Molecular Cancer Therapeutics, vol. 12, no. 4, pp. 499–508, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. F. Rencurel, M. Foretz, M. R. Kaufmann et al., “Stimulation of AMP-activated protein kinase is essential for the induction of drug metabolizing enzymes by phenobarbital in human and mouse liver,” Molecular Pharmacology, vol. 70, no. 6, pp. 1925–1934, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. S. Djafarzadeh, M. Vuda, J. Takala, M. Ochs, and S. M. Jakob, “Toll-like receptor-3-induced mitochondrial dysfunction in cultured human hepatocytes,” Mitochondrion, vol. 11, no. 1, pp. 83–88, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. F. Porta, J. Takala, C. Weikert et al., “Effects of prolonged endotoxemia on liver, skeletal muscle and kidney mitochondrial function,” Critical Care, vol. 10, no. 4, article R118, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. M. Vuda, L. Brander, R. Schröder, S. M. Jakob, J. Takala, and S. Djafarzadeh, “Effects of catecholamines on hepatic and skeletal muscle mitochondrial respiration after prolonged exposure to faecal peritonitis in pigs,” Innate Immunity, vol. 18, no. 2, pp. 217–230, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. H. Steen, J. G. Maring, and D. K. F. Meijer, “Differential effects of metabolic inhibitors on cellular and mitochondrial uptake of organic cations in rat liver,” Biochemical Pharmacology, vol. 45, no. 4, pp. 809–818, 1993. View at Publisher · View at Google Scholar · View at Scopus
  33. E. H. Carchman, S. Whelan, P. Loughran et al., “Experimental sepsis-induced mitochondrial biogenesis is dependent on autophagy, TLR4, and TLR9 signaling in liver,” FASEB Journal, vol. 27, no. 12, pp. 4703–4711, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. M. Růžička, E. Škobisová, A. Dlasková et al., “Recruitment of mitochondrial uncoupling protein UCP2 after lipopolysaccharide induction,” The International Journal of Biochemistry and Cell Biology, vol. 37, no. 4, pp. 809–821, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. H. J. Lee, Y. K. Oh, M. Rhee et al., “The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN,” Journal of Molecular Biology, vol. 369, no. 4, pp. 967–984, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  36. A. G. Testro and K. Visvanathan, “Toll-like receptors and their role in gastrointestinal disease,” Journal of Gastroenterology and Hepatology, vol. 24, no. 6, pp. 943–954, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. T. Matsumura, A. Ito, T. Takii, H. Hayashi, and K. Onozaki, “Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes,” Journal of Interferon and Cytokine Research, vol. 20, no. 10, pp. 915–921, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. H. B. He, X. L. Wu, B. Yu et al., “The effect of desacetyluvaricin on the expression of tlr4 and p53 protein in hepg 2.2.15,” Hepatitis Monthly, vol. 11, no. 5, pp. 364–367, 2011. View at Google Scholar · View at Scopus
  39. R. Tamura, T. Kanda, F. Imazeki et al., “Hepatitis C virus nonstructural 5A protein inhibits lipopolysaccharide-mediated apoptosis of hepatocytes by decreasing expression of toll-like receptor 4,” Journal of Infectious Diseases, vol. 204, no. 5, pp. 793–801, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. S. Akira, S. Uematsu, and O. Takeuchi, “Pathogen recognition and innate immunity,” Cell, vol. 124, no. 4, pp. 783–801, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. A. P. West, I. E. Brodsky, C. Rahner et al., “TLR signalling augments macrophage bactericidal activity through mitochondrial ROS,” Nature, vol. 472, no. 7344, pp. 476–480, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  42. B. S. Zuckerbraun, B. Y. Chin, M. Bilban et al., “Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species,” The FASEB Journal, vol. 21, no. 4, pp. 1099–1106, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. A. McGivney and S. G. Bradley, “Action of bacterial endotoxin and lipid A on mitochondrial enzyme activities of cells in culture and subcellular fractions,” Infection and Immunity, vol. 25, no. 2, pp. 664–671, 1979. View at Google Scholar · View at Scopus
  44. F. Porta, J. Takala, C. Weikert, P. Kaufmann, S. Krahenbuhl, and M. S. Jakob, “Effect of endotoxin, dobutamine and dopamine on muscle mitochondrial respiration in vitro,” Journal of Endotoxin Research, vol. 12, no. 6, pp. 358–366, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. T. Shibata, Y. Motoi, N. Tanimura, N. Yamakawa, S. Akashi-takamura, and K. Miyake, “Intracellular TLR4/MD-2 in macrophages senses Gram-negative bacteria and induces a unique set of LPS-dependent genes,” International Immunology, vol. 23, no. 8, pp. 503–510, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. S. Dunzendomfer, H. K. Lee, K. Soldau, and P. S. Tobias, “Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses,” FASEB Journal, vol. 18, no. 10, pp. 1117–1119, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. J. L. Dixon and H. N. Ginsberg, “Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells,” Journal of Lipid Research, vol. 34, no. 2, pp. 167–179, 1993. View at Google Scholar · View at Scopus
  48. M. T. Donato, A. Lahoz, J. V. Castell, and M. J. Gómez-Lechón, “Cell lines: a tool for in vitro drug metabolism studies,” Current Drug Metabolism, vol. 9, no. 1, pp. 1–11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Höschele, “Cell culture models for the investigation of NRTI-induced mitochondrial toxicity. Relevance for the prediction of clinical toxicity,” Toxicology in Vitro, vol. 20, no. 5, pp. 535–546, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus